002907 Share Price Performance
CN¥16.32
1.71 (11.70%)
Price CN¥16.32
Share PriceCN¥16.32
Pinning Down Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) P/S Is Difficult Right Now
Jan 13
Chongqing Pharscin Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002907 Community Narratives
There are no narratives available yet.
Chongqing Pharscin Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
- Earnings per share (EPS)
- 0.20
- Gross Margin
- 57.55%
- Net Profit Margin
- 10.45%
- Debt/Equity Ratio
- 0%
Chongqing Pharscin Pharmaceutical Co., Ltd. Competitors
Snowflake Analysis
About 002907
- Founded
- 1996
- Employees
- 1384
- CEO
- WebsiteView website
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was founded in 1996 and is headquartered in Chongqing, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.5%
- 3 Months: 17.0%
- 1 Year: 24.1%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Meanwhile, the market is actually up 24% over the past year. Earnings are forecast to grow by 27% annually. Market details ›